AI-generated summary
In a study of rats with streptozotocin-induced diabetes, the authors report that low-level laser therapy applied to a surgical tibia bone defect was associated with greater bending stiffness and maximum force at 42 days when a low dose was used. The authors note that LLLT is known to accelerate bone repair in healthy animals, and this was an animal study. Findings are reported as associations from a small experimental model.
- Who or what was studied
- Streptozotocin-induced diabetic rats and non-diabetic rats (28 rats total in five groups)
- Wavelengths
- 890 nm
- Limits stated in the abstract
- The study was conducted in rats with a small number of animals divided into five groups, so the results may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 890 nm
- Power
- 70 W
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Dose, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.